Back to RPRX
Douglas Lane & Associates, LLC → RPRX
Douglas Lane & Associates, LLC RPRX Position History
Royalty Pharma plc
Quarters held
4
Latest value
$53.2M
Q3 2026
Peak value
$63.2M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $49.1M |
| Q1 2026 | $63.2M |
| Q2 2026 | $52.6M |
| Q3 2026 | $53.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $53.2M | 1.09M | — | — |
| Q2 2026 | $52.6M | 1.13M | — | — |
| Q1 2026 | $63.2M | 1.23M | — | — |
| Q4 2025 | $49.1M | 1.28M | — | — |